Translational Cancer Research is indexed in SCIE
News

Translational Cancer Research is indexed in SCIE

Nancy Q. Zhong

Editorial Office, AME Publishing Company, Guangzhou 510220, China

Correspondence to: Nancy Q. Zhong. Editorial Office, AME Publishing Company, Guangzhou 510220, China. Email: tcr@amepc.org.

Submitted Oct 03, 2015. Accepted for publication Oct 03, 2015.

doi: 10.3978/j.issn.2218-676X.2015.10.11


In October 2015, Translational Cancer Research (TCR) was selected for coverage in Science Citation Index Expanded (SCIE), Thomson Reuters product. TCR articles from Volume 1, Number 1 will be indexed well in the database and be searchable online at the Web of KnowledgeTM core collection.

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org) is an open access, peer review journal published bimonthly both in print and online, published and run by AME Publishing Company. The operation of TCR journal is driven by the leadership and passion of Editor-in-Chief, Prof. Eric Chuang (National Taiwan University) and co-Editor-in-Chief, Dr. Huan Giap (Scripps Proton Therapy Center). Dr. Binghe Xu (Cancer Hospital and Institute, Chinese Academy of Medical Sciences) joined the journal as Associate Editor-in-Chief in 2014. They devote their time and bring their decades of experience in scientific research and publications for managing this journal.

The indexation of TCR journal 3 years upon its lunch in SCIE, a very important database, is a landmark to the journal. Since its launch in June 2012, TCR journal has been publishing timely and high-quality original articles and review articles as well as other article types authored by important researchers and clinicians in the field. The indexation makes these important articles part of the over 1 billion searchable, cited references in Web of Science, allowing TCR articles to be linked with studies of more researchers and clinicians internationally. Without any doubts, the database would increase the impact of TCR journal among other publications; meanwhile, hope the journal would add more significance to the database as well.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Translational Cancer Research. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.3978/j.issn.2218-676X.2015.10.11). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


Cite this article as: Zhong NQ. Translational Cancer Research is indexed in SCIE. Transl Cancer Res 2015;4(5):E16. doi: 10.3978/j.issn.2218-676X.2015.10.11

Download Citation